Filing Details
- Accession Number:
- 0001110803-14-000345
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-10-07 19:28:38
- Reporting Period:
- 2014-10-07
- Filing Date:
- 2014-10-07
- Accepted Time:
- 2014-10-07 19:28:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1008891 | Blaine A Bowman | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-10-07 | 4,456 | $19.61 | 17,178 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-10-07 | 900 | $158.59 | 16,278 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-07 | 2,056 | $159.40 | 14,222 | No | 4 | S | Direct | |
Common Stock | Disposition | 2014-10-07 | 1,500 | $160.21 | 12,722 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2014-10-07 | 4,456 | $0.00 | 4,456 | $19.61 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2008-01-26 | 2017-01-26 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 670 | Indirect | by Partnership |
Common Stock | 198 | Indirect | by Trust |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 900 shares sold ranging from $157.91 to $158.86 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 2,056 shares sold ranging from $158.93 to $159.86 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 1,500 shares sold ranging from $159.96 to $160.60 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.